Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0476
-0.0080 (-14.45%)
At close: Dec 15, 2025
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $1.99 million as of December 15, 2025. Its market cap has decreased by -94.39% in one year.
Market Cap
1.99M
Enterprise Value
-23.18K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.25
Stock Price
$0.05
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 1.99M, a decrease of -98.65%. That is a compound annual growth rate of -78.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 2.33M | -86.68% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |